HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VIGONVITA-B

82.400

+7.4009.87%

Volume:81.40K

Turnover:6.25M

Market Cap:13.84B

PE:-30.25

High:83.000

Open:75.050

Low:73.050

Close:75.000

52wk High:134.900

52wk Low:51.000

Shares:168.00M

HK Float Shares:167.00M

Volume Ratio:0.81

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-2.724

ROE:-123.98%

ROA:-20.73%

PB:55.20

PE(LYR):-30.25

PS:54.50

Loading ...

Overview Company News Filings

Vigonvita Life Sciences' 2025 Loss Widens

MT Newswires Live

Stock Track | Vigonvita Life Sciences Soars 5.29% Intraday on Proposed Capital Increase After H-Share Listing

Vigonvita proposes bylaw change to lift registered capital to RMB 168 million after H-share IPO

Vigonvita Life Sciences schedules extraordinary general meeting, sets share register book closure period

VIGONVITA-B Reports FY2025 Results: Shareholder Loss Widens to 356 Million Yuan

BRIEF-Vigonvita Life Sciences Posts FY Total Loss Attributable RMB355.7 Million

Vigonvita Life Sciences 2025: Revenue Jumps 7.63-fold but Loss Widens on Share-Based Payments and IPO Costs

Bulletin Express

Vigonvita Life Sciences Co Ltd - FY Total Loss Attributable RMB355.7 Mln

THOMSON REUTERS

Vigonvita Life Sciences Proposes Articles Amendment After H-Share Listing; Registered Capital to Rise to RMB167.60 Million

Bulletin Express

VIGONVITA-B (02630) EGM Green-lights H Share Award Scheme with 100% Support

Bulletin Express

Vigonvita Life Sciences Co. Ltd. held an extraordinary general meeting with 72.79% shareholder attendance

VIGONVITA-B (02630) Sets 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/02630/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02630\",,,,,undefined,":{"symbol":"02630","market":"HK","secType":"STK","nameCN":"VIGONVITA-B","latestPrice":82.4,"timestamp":1789373284004,"preClose":75,"halted":0,"volume":81400,"delay":0,"changeRate":0.09866666666666674,"floatShares":167000000,"shares":168000000,"eps":-2.7239528773226036,"marketStatus":"Closed","change":7.4,"latestTime":"09-14 16:08:04","open":75.05,"high":83,"low":73.05,"amount":6254250,"amplitude":0.132667,"askPrice":82.4,"askSize":1600,"bidPrice":80,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2.2125394926939457,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789435800000},"marketStatusCode":5,"adr":0,"listingDate":1762358400000,"exchange":"SEHK","adjPreClose":75,"openAndCloseTimeList":[[1789349400000,1789358400000],[1789362000000,1789372800000]],"volumeRatio":0.808824,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02630\",,,,,undefined,":{"symbol":"02630","floatShares":167000000,"roa":"-20.73%","roe":"-123.98%","lyrEps":-2.723953,"volumeRatio":0.808824,"shares":168000000,"dividePrice":0,"high":83,"amplitude":0.132667,"preClose":75,"low":73.05,"week52Low":51,"pbRate":"55.20","psRate":"54.50","week52High":134.9,"institutionHeld":0,"latestPrice":82.4,"committee":-0.777778,"eps":-2.7239528773226036,"divideRate":0,"volume":81400,"delay":0,"ttmEps":-2.2125394926939457,"open":75.05,"prevYearClose":81.85,"prevWeekClose":75,"prevMonthClose":99.2,"prevQuarterClose":63.55,"fiveDayClose":94,"twentyDayClose":92.65,"sixtyDayClose":58.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02630\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02630","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null},{"date":"2026-03-31","symbol":"02630","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774920600000,"name":null,"time":"","dateTimestamp":1774886400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02630\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02630\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02630\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02630","date":"2026-09-11","current":-37.242273,"percent":0.158654,"low":-51.703739,"twenty":-33.782678,"median":-24.094013,"eighty":-18.485229,"high":-9.647367,"avg":-25.725705,"sd":9.018534,"marketCap":12569835000},"quantilePoints":[{"date":"2025-11-07","current":-19.090342,"twenty":-21.84559,"median":-19.090342,"eighty":-13.424557,"marketCap":4407358491},{"date":"2025-11-14","current":-19.641187,"twenty":-19.420849,"median":-16.095168,"eighty":-15.264414,"marketCap":4547380470},{"date":"2025-11-21","current":-17.28769,"twenty":-19.452561,"median":-18.09445,"eighty":-15.501254,"marketCap":4000627980},{"date":"2025-11-28","current":-20.095977,"twenty":-19.591091,"median":-19.037434,"eighty":-16.046947,"marketCap":4667399310},{"date":"2025-12-05","current":-22.096294,"twenty":-21.259546,"median":-19.451229,"eighty":-16.716837,"marketCap":5140806954},{"date":"2025-12-12","current":-20.997063,"twenty":-21.601599,"median":-19.578567,"eighty":-17.610394,"marketCap":4894101562},{"date":"2025-12-19","current":-23.416326,"twenty":-21.853997,"median":-20.095977,"eighty":-18.35497,"marketCap":5470858762},{"date":"2025-12-24","current":-23.9553,"twenty":-22.587001,"median":-20.380599,"eighty":-18.745749,"marketCap":5614214598},{"date":"2026-01-02","current":-23.818881,"twenty":-23.195416,"median":-20.975608,"eighty":-18.936771,"marketCap":5604213028},{"date":"2026-01-09","current":-24.028271,"twenty":-23.242124,"median":-21.499422,"eighty":-19.069179,"marketCap":5667556305},{"date":"2026-01-16","current":-25.359291,"twenty":-23.625318,"median":-21.781264,"eighty":-19.370201,"marketCap":6000941970},{"date":"2026-01-23","current":-26.793845,"twenty":-23.828886,"median":-22.096294,"eighty":-19.449016,"marketCap":6334327635},{"date":"2026-01-30","current":-27.921283,"twenty":-24.928673,"median":-22.61666,"eighty":-19.453005,"marketCap":6631040876},{"date":"2026-02-06","current":-29.544924,"twenty":-25.987891,"median":-22.879289,"eighty":-19.503447,"marketCap":7034437531},{"date":"2026-02-13","current":-30.629205,"twenty":-27.286118,"median":-23.1966,"eighty":-19.616139,"marketCap":7334484630},{"date":"2026-02-20","current":-34.884005,"twenty":-27.587073,"median":-23.306067,"eighty":-19.674728,"marketCap":8341309338},{"date":"2026-02-27","current":-31.168111,"twenty":-28.783656,"median":-23.424434,"eighty":-19.866309,"marketCap":7534516029},{"date":"2026-03-06","current":-27.5285,"twenty":-28.691787,"median":-23.667752,"eighty":-20.125096,"marketCap":6601036167},{"date":"2026-03-13","current":-30.889856,"twenty":-29.277344,"median":-23.818881,"eighty":-20.297184,"marketCap":7441168042},{"date":"2026-03-20","current":-35.008205,"twenty":-30.149829,"median":-23.991785,"eighty":-20.606532,"marketCap":8401318758},{"date":"2026-03-27","current":-24.261842,"twenty":-30.04822,"median":-24.440897,"eighty":-20.962736,"marketCap":5807578284},{"date":"2026-04-02","current":-13.839173,"twenty":-29.95186,"median":-24.028271,"eighty":-20.954154,"marketCap":5600879172},{"date":"2026-04-10","current":-14.403566,"twenty":-29.707698,"median":-23.912102,"eighty":-20.183335,"marketCap":5874255417},{"date":"2026-04-17","current":-13.931767,"twenty":-29.472848,"median":-23.687448,"eighty":-19.490947,"marketCap":5684225588},{"date":"2026-04-24","current":-13.154764,"twenty":-29.345649,"median":-23.63573,"eighty":-19.048016,"marketCap":5367509206},{"date":"2026-04-30","current":-11.730061,"twenty":-29.261806,"median":-23.42038,"eighty":-17.610394,"marketCap":4787418149},{"date":"2026-05-08","current":-12.584922,"twenty":-29.118763,"median":-23.285925,"eighty":-15.264414,"marketCap":5154142380},{"date":"2026-05-15","current":-12.982213,"twenty":-28.928188,"median":-23.15168,"eighty":-14.197911,"marketCap":5330836783},{"date":"2026-05-22","current":-13.28049,"twenty":-28.680958,"median":-22.671486,"eighty":-13.975486,"marketCap":5440854052},{"date":"2026-05-29","current":-30.758632,"twenty":-28.951155,"median":-22.671486,"eighty":-13.922465,"marketCap":12645254010},{"date":"2026-06-05","current":-26.663627,"twenty":-28.786309,"median":-23.15168,"eighty":-13.953626,"marketCap":10977655900},{"date":"2026-06-12","current":-24.767111,"twenty":-28.478214,"median":-23.285925,"eighty":-14.04116,"marketCap":10189946240},{"date":"2026-06-18","current":-23.79348,"twenty":-28.413466,"median":-23.416326,"eighty":-14.041546,"marketCap":9812851190},{"date":"2026-06-26","current":-24.094013,"twenty":-28.02179,"median":-23.475951,"eighty":-14.17377,"marketCap":9888270200},{"date":"2026-07-03","current":-23.973985,"twenty":-27.941384,"median":-23.572922,"eighty":-14.1825,"marketCap":9846370750},{"date":"2026-07-10","current":-22.062739,"twenty":-27.729315,"median":-23.424434,"eighty":-14.21114,"marketCap":9050281200},{"date":"2026-07-17","current":-23.043014,"twenty":-27.655709,"median":-23.42038,"eighty":-14.359864,"marketCap":9486035480},{"date":"2026-07-24","current":-31.748257,"twenty":-27.941384,"median":-23.52511,"eighty":-14.401931,"marketCap":13072628400},{"date":"2026-07-31","current":-38.65537,"twenty":-28.640355,"median":-23.612983,"eighty":-14.919422,"marketCap":15946930670},{"date":"2026-08-07","current":-47.358881,"twenty":-29.345649,"median":-23.667752,"eighty":-15.264958,"marketCap":19575423040},{"date":"2026-08-14","current":-37.215568,"twenty":-30.11107,"median":-23.79348,"eighty":-15.618859,"marketCap":15402237820},{"date":"2026-08-21","current":-35.214198,"twenty":-30.680976,"median":-23.843893,"eighty":-16.143388,"marketCap":14606148270},{"date":"2026-08-28","current":-40.255874,"twenty":-31.400169,"median":-23.9553,"eighty":-16.907121,"marketCap":16701120770},{"date":"2026-09-04","current":-44.821322,"twenty":-32.610186,"median":-24.007881,"eighty":-17.771746,"marketCap":15938550780},{"date":"2026-09-11","current":-35.300408,"twenty":-33.782678,"median":-24.094013,"eighty":-18.485229,"marketCap":12569835000}],"updateTime":1789383821066},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02630\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624569473","title":"Vigonvita Life Sciences' 2025 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2624569473","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624569473?lang=en_us&edition=fundamental","pubTime":"2026-04-01 12:46","pubTimestamp":1775018812,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences  booked 355.7 million yuan in loss for 2025, 68% higher from the 211.4 million yuan loss booked in 2024, according to a Hong Kong bourse filing Tuesday.Shares of the drug discovery firm gained over 3% in late morning trade Wednesday.Loss per share was 2.33 yuan, compared with 1.45 yuan in the prior year.Revenue rose to 102.1 million yuan from 11.8 million yuan in 2024.The firm attributed the increase in revenue to the marketing approval of its TPN171 drug during the year, as well as milestone payments tied to the VV116 medicine.The company did not declare any dividend for the year.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119592422","title":"Stock Track | Vigonvita Life Sciences Soars 5.29% Intraday on Proposed Capital Increase After H-Share Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1119592422","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119592422?lang=en_us&edition=fundamental","pubTime":"2026-04-01 09:59","pubTimestamp":1775008770,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) saw its stock price soar 5.29% during intraday trading on Wednesday, reflecting significant investor interest.The surge follows the company's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624109556","title":"Vigonvita proposes bylaw change to lift registered capital to RMB 168 million after H-share IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2624109556","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624109556?lang=en_us&edition=fundamental","pubTime":"2026-04-01 06:12","pubTimestamp":1774995124,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences proposed bylaw amendments to reflect changes following H-share listing on Nov. 6, 2025.Registered capital would be updated to RMB 168 million from RMB 150 million.Changes would require shareholder clearance via special resolution at forthcoming extraordinary general meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vigonvita Life Sciences Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL4919vT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624556659","title":"Vigonvita Life Sciences schedules extraordinary general meeting, sets share register book closure period","url":"https://stock-news.laohu8.com/highlight/detail?id=2624556659","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624556659?lang=en_us&edition=fundamental","pubTime":"2026-04-01 06:04","pubTimestamp":1774994692,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences scheduled an extraordinary general meeting for April 23, 2026 at 10:00 a.m. in Suzhou, China.H-share register will close April 20-23, 2026 to set voting eligibility for the meeting.H-share transfer deadline for meeting eligibility set for April 17, 2026 at 4:30 p.m. Hong Kong time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vigonvita Life Sciences Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL53vPYl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166352107","title":"VIGONVITA-B Reports FY2025 Results: Shareholder Loss Widens to 356 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1166352107","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166352107?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:58","pubTimestamp":1774972704,"startTime":"0","endTime":"0","summary":"VIGONVITA-B (02630) announced its annual results for the period ended December 31, 2025. The company recorded revenue of 102 million yuan, representing a significant increase of 762.9% compared to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623533184","title":"BRIEF-Vigonvita Life Sciences Posts FY Total Loss Attributable RMB355.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623533184","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623533184?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:23","pubTimestamp":1774970639,"startTime":"0","endTime":"0","summary":"BRIEF-Vigonvita Life Sciences Posts FY Total Loss Attributable RMB355.7 MillionMarch 31 (Reuters) - Vigonvita Life Sciences Co Ltd 2630.HK:FY TOTAL LOSS ATTRIBUTABLE RMB355.7 MILLIONFY REVENUE RMB102.1 MILLIONFurther company coverage: 2630.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J1N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159080130","title":"Vigonvita Life Sciences 2025: Revenue Jumps 7.63-fold but Loss Widens on Share-Based Payments and IPO Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=1159080130","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159080130?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:07","pubTimestamp":1774969638,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. reported audited results for the year ended 31 December 2025. Financial Snapshot   • Revenue surged to RMB 102.10 million, up 762.9% year-on-year, driven by the July...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623453814","title":"Vigonvita Life Sciences Co Ltd -  FY Total Loss Attributable RMB355.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2623453814","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623453814?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:52","pubTimestamp":1774968761,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J1N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130638221","title":"Vigonvita Life Sciences Proposes Articles Amendment After H-Share Listing; Registered Capital to Rise to RMB167.60 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1130638221","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130638221?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:27","pubTimestamp":1774967232,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) has released an announcement detailing plans to amend multiple clauses in its Articles of Association following the company’s H-share listing on 6...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158487800","title":"VIGONVITA-B (02630) EGM Green-lights H Share Award Scheme with 100% Support","url":"https://stock-news.laohu8.com/highlight/detail?id=1158487800","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158487800?lang=en_us&edition=fundamental","pubTime":"2026-03-19 22:00","pubTimestamp":1773928859,"startTime":"0","endTime":"0","summary":"On 19 March 2026, Vigonvita-B (02630) announced the poll results of its Extraordinary General Meeting held the same day in Suzhou. The sole agenda item—adoption of an H Share Award Scheme and related...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620265022","title":"Vigonvita Life Sciences Co. Ltd. held an extraordinary general meeting with 72.79% shareholder attendance","url":"https://stock-news.laohu8.com/highlight/detail?id=2620265022","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620265022?lang=en_us&edition=fundamental","pubTime":"2026-03-19 21:45","pubTimestamp":1773927940,"startTime":"0","endTime":"0","summary":"Shareholders approved the adoption of the H Share Award Scheme.The meeting also approved authorizing the board to handle matters related to the H Share Award Scheme.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vigonvita Life Sciences Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 19, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDLw5zX5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130554739","title":"VIGONVITA-B (02630) Sets 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1130554739","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130554739?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:23","pubTimestamp":1773872594,"startTime":"0","endTime":"0","summary":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B, 02630) has announced that its board of directors will convene on 31 March 2026. The agenda includes: • Reviewing and approving the Group’s audited...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":52,"code":"91000000","status":"200"}]}}